Yuh‐Seog Jung

1.4k total citations
48 papers, 696 citations indexed

About

Yuh‐Seog Jung is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Otorhinolaryngology. According to data from OpenAlex, Yuh‐Seog Jung has authored 48 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 15 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Otorhinolaryngology. Recurrent topics in Yuh‐Seog Jung's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Head and Neck Cancer Studies (11 papers) and Thyroid and Parathyroid Surgery (8 papers). Yuh‐Seog Jung is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Head and Neck Cancer Studies (11 papers) and Thyroid and Parathyroid Surgery (8 papers). Yuh‐Seog Jung collaborates with scholars based in South Korea, United States and Switzerland. Yuh‐Seog Jung's co-authors include Junsun Ryu, Chang Hwan Ryu, Hyun Joo Ahn, Ji Yeon Kim, W. Keith Miskimins, Joon Young Choi, Jungirl Seok, Eun Kyung Lee, Weon Seo Park and Kyu‐Won Jung and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Yuh‐Seog Jung

43 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuh‐Seog Jung South Korea 15 225 224 188 170 116 48 696
Gerd Lorenz Germany 14 133 0.6× 107 0.5× 190 1.0× 114 0.7× 41 0.4× 36 586
Debbie Chen United States 15 174 0.8× 294 1.3× 276 1.5× 177 1.0× 83 0.7× 41 920
San‐Chi Chen Taiwan 16 118 0.5× 64 0.3× 128 0.7× 260 1.5× 74 0.6× 53 785
S. Seitz Germany 12 93 0.4× 131 0.6× 222 1.2× 122 0.7× 40 0.3× 22 827
Mette Gyldenløve Denmark 13 130 0.6× 63 0.3× 126 0.7× 114 0.7× 50 0.4× 31 596
Eun‐Jung Jung South Korea 16 325 1.4× 146 0.7× 167 0.9× 275 1.6× 114 1.0× 86 823
John R. Barber United States 15 68 0.3× 63 0.3× 169 0.9× 174 1.0× 142 1.2× 40 652
Hélène Dulude Canada 16 160 0.7× 326 1.5× 134 0.7× 193 1.1× 60 0.5× 37 798
Aura D. Herrera‐Martínez Spain 17 96 0.4× 129 0.6× 169 0.9× 255 1.5× 86 0.7× 67 729
Thomas A Ratko United States 16 91 0.4× 51 0.2× 172 0.9× 143 0.8× 53 0.5× 32 813

Countries citing papers authored by Yuh‐Seog Jung

Since Specialization
Citations

This map shows the geographic impact of Yuh‐Seog Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuh‐Seog Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuh‐Seog Jung more than expected).

Fields of papers citing papers by Yuh‐Seog Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuh‐Seog Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuh‐Seog Jung. The network helps show where Yuh‐Seog Jung may publish in the future.

Co-authorship network of co-authors of Yuh‐Seog Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Yuh‐Seog Jung. A scholar is included among the top collaborators of Yuh‐Seog Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuh‐Seog Jung. Yuh‐Seog Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seok, Jungirl, Hongyoon Choi, Eun Kyung Lee, et al.. (2025). Tumor microenvironment remodeling across thyroid cancer differentiation states revealed by spatial transcriptomics. Cancer Immunology Immunotherapy. 74(12). 357–357.
2.
Lee, Hwi‐Ho, Yeon-Su Lee, Yeon-Su Lee, et al.. (2024). Adenovirus expressing nc886, an anti-interferon and anti-apoptotic non-coding RNA, is an improved gene delivery vector. Molecular Therapy — Nucleic Acids. 35(3). 102270–102270. 1 indexed citations
3.
Kim, Seok-ki, Jungirl Seok, Chang Yoon Lee, et al.. (2024). The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer. Annals of Surgical Oncology. 31(4). 2349–2356. 1 indexed citations
4.
Moon, Hyunjin, Chang Hwan Ryu, Yuh‐Seog Jung, et al.. (2023). Novel thrombospondin-1 transcript exhibits distinctive expression and activity in thyroid tumorigenesis. Oncogene. 42(22). 1832–1842. 6 indexed citations
6.
So, Yoon Kyoung, Myung Jin Chung, Myung Jin Chung, et al.. (2023). Detection of Cancer Recurrence Using Systemic Inflammatory Markers and Machine Learning after Concurrent Chemoradiotherapy for Head and Neck Cancers. Cancers. 15(14). 3540–3540. 2 indexed citations
7.
Jung, Yuh‐Seog, et al.. (2022). Long-term Survivorship and Non-cancer Competing Mortality in Head and Neck Cancer: A Nationwide Population-Based Study in South Korea. Cancer Research and Treatment. 55(1). 50–60. 5 indexed citations
8.
Moon, Hyunjin, Chang Hwan Ryu, Jungirl Seok, et al.. (2021). Quercetin Induces Anticancer Activity by Upregulating Pro-NAG-1/GDF15 in Differentiated Thyroid Cancer Cells. Cancers. 13(12). 3022–3022. 32 indexed citations
9.
Oh, Jin‐Kyoung, et al.. (2021). Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea. Epidemiology and Health. 43. e2021019–e2021019. 3 indexed citations
10.
Seok, Jungirl, Chang Hwan Ryu, Seog Yun Park, et al.. (2021). Factors Affecting Central Node Metastasis and Metastatic Lymph Node Ratio in Papillary Thyroid Cancer. Otolaryngology. 165(4). 519–527. 11 indexed citations
11.
Shin, Seung-Pil, Seok‐Jun Kim, Jong-Kwang Kim, et al.. (2021). Local adenoviral delivery of soluble CD200R-Ig enhances antitumor immunity by inhibiting CD200-β-catenin-driven M2 macrophage. Molecular Therapy — Oncolytics. 23. 138–150. 8 indexed citations
12.
Kameda-Smith, Michelle, et al.. (2021). Advances in Mechanical Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion. Critical Reviews in Biomedical Engineering. 49(5). 13–70. 4 indexed citations
13.
Lee, Eun Kyung, Hwa Young Ahn, Eu Jeong Ku, et al.. (2021). Cardiovascular Outcomes in Thyroid Cancer Patients Treated With Thyroidectomy: A Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism. 106(12). 3644–3654. 14 indexed citations
14.
Trần, Thị Xuân Mai, et al.. (2020). Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health outcomes in cancer patients: a systematic review. Supportive Care in Cancer. 29(4). 1723–1739. 12 indexed citations
17.
Shin, Seung-Pil, Ah Ra Goh, Seok‐Jun Kim, et al.. (2019). CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation. Cancers. 11(10). 1583–1583. 15 indexed citations
19.
Jung, Yuh‐Seog, Chang‐Mo Oh, Yeol Kim, et al.. (2018). Long-term survival of patients with thyroid cancer according to the methods of tumor detection: A nationwide cohort study in Korea. PLoS ONE. 13(4). e0194743–e0194743. 9 indexed citations
20.
Miskimins, W. Keith, et al.. (2014). Synergistic Anti-Cancer Effect of Phenformin and Oxamate. PLoS ONE. 9(1). e85576–e85576. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026